Value-based care has become one of the most pressing challenges, and opportunities, in orthopedic and spine surgery. Rising costs, increasing case complexity and shifting expectations from patients and payers are forcing health systems to rethink how they deliver care long before a patient enters...

Distalmotion has closed a $150 million Series G funding round to accelerate US adoption of its Dexter robotic surgery system, focusing on the Ambulatory Surgery Center market and continued clinical and product development.

/PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced U.S. Food and Drug Administration (FDA)...

Featuring prominently in NeuroNews’ latest top 10 are a number of stories relating to the real-world implementation of mechanical thrombectomy treatments—including a new study emphasising the impact of procedural duration relative to prehospital delays, an industry update demonstrating the ability...

By VisionMed Collaboration to advance TROGSS programs in training, education, and research CHICAGO, IL, UNITED STATES, October 10, 2025 /EINPresswire.com/ — VisionMed, a leader in AI video analysis and documentation technology, and TROGSS – The Robotic Global Surgery Society announced a landmark partnership to collaborate on advancing education, training, and research in robotic surgery. The announcement was made to coincide with the American College of Surgeons Clinical Congress 2025 in Chicago, underscoring the growing global emphasis on integrating AI and advanced documentation into surgical training and practice. Through this partnership, VisionMed’s EMMA™ AI platform will be integrated into TROGSS’ programs to support physician training, continuing medical education (CME), and scientific exchange. VisionMed will provide demonstrations, training licenses, and technical support for TROGSS’ educational activities, while ensuring compliance with CME and nonprofit standards. As part of the agreement, VisionMed will sponsor the TROGSS Intercontinental Congress in Luxembourg in July 2026 and support initiatives such as the Traveling Scholar Awards. EMMA™ will also contribute to simulation-based and dry lab training within the CARS (Competency-Based Assessment of Robotic Surgery Skills) Curriculum for the TROGSS Intercontinental Training Program (ITP). Both organizations will collaborate on research and publications highlighting the role of AI video analysis in surgical education, documentation, and quality improvement. “This partnership reflects our ongoing commitment to advancing surgical education through innovation with advanced technology at the service of medicine and humanity, and a patient-centered approach in all of our endeavors together,” said Prof. Rodolfo J. Oviedo, MD, FACS, FRCS, FICS, FASMBS, DABS-FPDMBS, who serves as CEO of TROGSS. “By incorporating VisionMed’s AI technology into our educational and research programs, we are equipping our worldwide members and surgical community with cutting-edge tools that enhance training and documentation. We are truly honored and privileged at TROGSS to have VisionMed as a distinguished industry partner. We have the deepest admiration and respect for what they do and who they are.” “VisionMed is honored to partner with TROGSS, an organization doing exceptional work to expand access to training and advance the global standard of robotic surgery,” said David MacLean, CEO of VisionMed. “By supporting their initiatives, we aim to complement TROGSS’ mission with AI-driven tools that enhance education, documentation, and efficiency for surgeons worldwide.” About VisionMedVisionMed is an AI video analysis company specializing in surgical documentation and workflow support. Its EMMA™ platform converts surgical video into organized, time-stamped records and efficiency insights, helping hospitals, educators, and surgeons improve training, reporting, and operational performance. About TROGSSTROGSS – The Robotic Global Surgery Society (https://trogss.org) is an international nonprofit professional surgical society dedicated to advancing robotic surgery through education, training, research, and collaboration. With members spanning multiple specialties and most continents, TROGSS leads initiatives such as the Intercontinental Training Program (ITP), global congresses, and multicenter research studies to promote innovation, skill development, and equitable access to robotic surgery worldwide. With the motto “Advancing Robotic Surgery and Education, for Our Patients, by Our Surgeons,” its mission and reason to exist is #surgicaleducationforall. Media ContactsVisionMed: Dave@Visionmed.usTROGSS: trogssofficial@gmail.com David MacLeanVisionMedDave@visionmed.us Legal Disclaimer: EIN Presswire provides this news content “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

There is no report upon the remote surgery of radical prostatectomy and comparisons between local surgeries. This study aims to evaluate the feasibility and safety of the innovative remote tele-surgical robotic platforms in performing radical prostatectomy.

Executives also addressed Medicaid concerns and competition from third-party suppliers of remanufactured surgical instruments on an earnings call.

Will Elon Musk's Tesla robot be able to perform surgery? What does this mean for patients? And, how are surgeons currently using robots in surgery?

Explore robotic innovations in healthcare delivery, enhancing surgeries, diagnostics, & patient care. Learn about the challenges & opportunities.

With AI-guided navigation through the implant planning, imaging and surgical process, Yomi S offers safer procedures.

Researchers at the University of Dundee have pioneered a new chapter in stroke treatment by successfully performing the first robotic transatlantic...

Companies creating new robotic platforms marked additional milestones heading into the fourth quarter. Catch up with their progress in this roundup of the latest developments in surgical robotics.

Can the stock still deliver the same kinds of returns it has over the past few decades?

Recent analyses have shown that da Vinci robotic surgery achieves a 99% reliability rate, with technical issues rarely affecting patient outcomes.

The prevalence of obesity has reached epidemic proportions globally, with obese patients facing significantly higher perioperative risks due to anatomical and physiological challenges. While robot-assisted surgery (RAS) offers potential advantages through 3D high-definition imaging and tremor...